Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Liu, Qingyun ^a,b   Via, Laura E ^b,c   Luo, Tao ^a   Liang, Lili ^d   Liu, Xin ^d   Wu, Sufang ^d   Shen, Qingyu ^e   Wei, Wang ^d   Ruan, Xianglin ^d   Yuan, Xing ^d   Zhang, Guolong ^e   Barry, Clifton E ^b,c   Gao, Qian ^a,e  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Henan Provincial Chest Hospital   (China)

^e Sino US International Research Center of Tuberculosis   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; FEMALE; GENETICS; HUMAN; MOLECULAR EVOLUTION; MYCOBACTERIUM TUBERCULOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

ADULT; ALLELES; EVOLUTION, MOLECULAR; FEMALE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUBERCULOSIS;

EID: 84949194114     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17507     Document Type: Article

References (39)

1. Hingley-Wilson, S. M. et al. Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. Emerg Infect Dis 19, 1138-1141 (2013).
2. Niemann, S., Richter, E., Rusch-Gerdes, S., Schlaak, M., Greinert, U. Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis. Emerg Infect Dis 6, 548-551 (2000).
3. Sun, G. et al. Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J Infect Dis 206, 1724-1733 (2012).
4. Rinder, H., Mieskes, K. T., Loscher, T. Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 5, 339-345 (2001).
5. Liu, Q., Luo, T., Li, J., Mei, J., Gao, Q. Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction. J Antimicrob Chemother 68, 1097-1103 (2013).
6. Mariam, S. H., Werngren, J., Aronsson, J., Hoffner, S., Andersson, D. I. Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment. PLoS One 6, e21147 (2011).
7. Theisen, A. et al. Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis. Lancet 345, 1512 (1995).
8. Post, F. A. et al. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. J Infect Dis 190, 99-106 (2004).
9. Merker, M. et al. Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients. PLoS One 8, e82551 (2013).
10. Eldholm, V. et al. Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient. Genome Biol 15, 490 (2014).
11. Kaplan, G. et al. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun 71, 7099-7108 (2003).
12. Vadwai, V. et al. Clonal population of Mycobacterium tuberculosis strains reside within multiple lung cavities. PLoS One 6, e24770 (2011).
13. Zhang, H. et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet 45, 1255-1260 (2013).
14. Farhat, M. R. et al. Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat Genet 45, 1183-1189 (2013).
15. Ford, C. B. et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet 43, 482-486 (2011).
16. Pang, Y. et al. Prevalence and risk factors of mixed Mycobacterium tuberculosis complex infections in China. J Infect 71, 231-237 (2015).
17. Peng, Y. et al. Multiple samples improve the sensitivity for detection of mixed Mycobacterium infections. Tuberculosis (Edinb) 93, 548-550 (2013).
18. Fang, R. et al. Mixed infections of Mycobacterium tuberculosis in tuberculosis patients in Shanghai, China. Tuberculosis (Edinb) 88, 469-473 (2008).
19. Bryant, J. M. et al. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir Med 1, 786-792 (2013).
20. Koser, C. U. et al. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N Engl J Med 369, 290-292 (2013).
21. Perez-Lago, L. et al. Whole Genome Sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: Potential impact on the inference of tuberculosis transmission. J Infect Dis 209, 98-108 (2014).
22. Walker, T. M. et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 13, 137-146 (2013).
23. Miotto, P. et al. Genome-wide discovery of small RNAs in Mycobacterium tuberculosis. PLoS One 7, e51950 (2012).
24. Perez-Lago, L. et al. Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission. J Infect Dis 209, 98-108 (2014).
25. Ahmad Khan, F., Behr, M. Resistant plus susceptible tuberculosis: the undiscovered country. J Infect Dis 209, 1682-1684 (2014).
26. Zetola, N. M. et al. Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests. J Infect Dis 209, 1754-1763 (2014).
27. Swanton, C. Cancer evolution: the final frontier of precision medicine Ann Oncol 25, 549-551 (2014).
28. Gerlinger, M. et al. Cancer: evolution within a lifetime. Annu Rev Genet 48, 215-236 (2014).
29. Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256-259 (2014).
30. de Bruin, E. C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251-256 (2014).
31. Alderton, G. K. Tumour evolution: clonal ancestry in lung cancer. Nat Rev Cancer 14, 763 (2014).
32. Lambert, G. et al. An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer 11, 375-382 (2011).
33. Via, L. E. et al. Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [(1)(8)F]2-fluorodeoxy-D-glucose positron emission tomography and computed tomography. Antimicrob Agents Chemother 56, 4391-4402 (2012).
34. Lin, P. L. et al. Radiologic responses in cynomolgous macaques for assessing tuberculosis chemotherapy regimens. Antimicrob Agents Chemother 57, 4237-4244 (2013).
35. Lin, P. L. et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med 20, 75-79 (2014).
36. Li, H., Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
37. Wilm, A. et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 40, 11189-11201 (2012).
38. Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22, 568-576 (2012).
39. Luo, T. et al. Development of a hierarchical variable-number tandem repeat typing scheme for Mycobacterium tuberculosis in China. PLoS One 9, e89726 (2014).